ASTELLAS PHARMA
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 2005-01-01
- Employees
- -
- Market Cap
- $22.5B
- Website
- https://www.astellas.com/
A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-B
- First Posted Date
- 2010-05-18
- Last Posted Date
- 2010-05-25
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 44
- Registration Number
- NCT01125657
A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 Tablet
- First Posted Date
- 2010-05-18
- Last Posted Date
- 2010-05-25
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 24
- Registration Number
- NCT01125670
A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug
Phase 1
Completed
- Conditions
- HealthyPharmacokinetics of ASP1585
- Interventions
- Drug: 14C-Labeled ASP1585
- First Posted Date
- 2010-05-17
- Last Posted Date
- 2014-05-05
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 12
- Registration Number
- NCT01124747
A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment
Completed
- Conditions
- Overactive Bladder
- First Posted Date
- 2010-05-13
- Last Posted Date
- 2011-01-13
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 55
- Registration Number
- NCT01122563
Reproducibility Study of Overactive Bladder Symptom Score [OABSS]
Completed
- Conditions
- Overactive Bladder
- First Posted Date
- 2010-05-13
- Last Posted Date
- 2010-08-24
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 50
- Registration Number
- NCT01122550
A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects
- First Posted Date
- 2010-05-13
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 252
- Registration Number
- NCT01122368
A Study to Assess Safety and Tolerability of ASP1941 After Single and Repeated Administration in Healthy Subjects
Phase 1
Completed
- Conditions
- Pharmacokinetics of ASP1941Healthy Volunteer
- Interventions
- Drug: placebo
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2010-05-12
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 84
- Registration Number
- NCT01121198
A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2010-05-06
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 24
- Registration Number
- NCT01118559
A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain Patients
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 616
- Registration Number
- NCT01118572
A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus
Phase 2
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2010-05-05
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 343
- Registration Number
- NCT01117584
© Copyright 2025. All Rights Reserved by MedPath